Breaking News

UCB SA ADR (UCBJY)

Symbol	Exchange	Currency
UCBJY	OTC Markets	USD	Delayed
UCBb	BATS Europe	EUR	Delayed
0NZT	London	EUR	Real-time
UCB	Frankfurt	EUR	Delayed
UCB	TradeGate	EUR	Delayed
UCB	Brussels	EUR	Real-time
UCB	Vienna	EUR	Real-time

Add to/Remove from a Portfolio Add to Watchlist

139.39 +1.52 +1.10%

28/11 - Closed. Currency in USD

Type: Equity

Market: United States

Volume: 6,516
Bid/Ask: 0.00 / 0.00
Day's Range: 138.21 - 140.44

General
Chart
- Streaming charts
- Interactive Chart
News & Analysis
- News
- Analysis & Comment
Financials
Technical
Forum

UCB SA ADR Company Profile

Get an in-depth profile of UCB SA ADR, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryPharmaceuticals

SectorHealthcare

Employees

9215

Equity Type

ADR

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company’s primary products include Cimzia for inflammatory TNF-mediated diseases, as well as ankylosing spondylitis (AS), axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; and Neupro for Parkinson’s disease and restless legs syndrome. It also provides Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. In addition, the company offers Evenity for the treatment of osteoporosis in postmenopausal women; Bimzelx to treat plaque psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; Fintepla for the treatment of Dravet/Lennox-Gastaut syndrome; and RYSTIGGO and ZILBRYSQ to treat people living with generalized myasthenia gravis. Further, it develops doxecitine/doxribtimine for TK2 deficiency disorder; fenfluramine to treat CDKL5 deficiency disorder; dapirolizumab pegol for systemic lupus erythematosus; STACCATO alprazolam for treating stereotypical prolonged seizures; bepranemab to treat Alzheimer’s disease; UCB0222 for the treatment of Parkinson’s disease; and UCB9741 and UCB1381 for atopic dermatitis. Additionally, it engages in the contract manufacturing activities. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.

Contact Information

Address Allée de la Recherche, 60
Brussels, 1070
Belgium

Phone 32 2 559 99 99

Fax 32 2 559 99 00

Web www.ucb.com

Top Executives

Name	Age	Since	Title
Georges Jacobs de Hagen	85	2005	Honorary Chairman
Daniel Janssen	89	-	Honorary Deputy Chairman
Jonathan M. Peacock	67	2021	Independent Chair of the Board
Diégo du Monceau de Bergendal	75	1984	Honorary Chairman
Gerhard N. Mayr	79	2005	Honorary Chairman
Mark Eyskens	-	2005	Honorary Chairman
Karel Boone	82	2000	Honorary Chairman
Jonkheer Cédric van Rijckevorsel	55	2014	Director
Charles-Antoine Emmanuel T. Janssen	54	2012	Vice-Chair of the Board
Ulf Arne Wiinberg	67	2016	Independent Director
Jean-Christophe Tellier	66	2014	CEO & Executive Director
Cyril Janssen	54	2015	Director
Jan Berger	68	2019	Independent Director
Rodolfo J. Savitzky	63	2024	Independent Director
Dame Kay Davies	74	2014	Independent Director
Guy Keutgen	-	1990	Honorary Director
Gaëtan van de Werve	-	2006	Honorary Director
Jean-Pierre Kinet	72	2008	Honorary Director
Prince Lorenz	-	2001	Honorary Director
Jean-Louis Vanherweghem	-	-	Honorary Director
Frederic Roch Doliveux	69	2005	Honorary Director
Peter J. Fellner	82	2005	Honorary Director
Albrecht De Graeve	70	2010	Honorary Director
Norman J. Ornstein	77	2008	Honorary Director
Arnoud de Pret Roose de Calesberg	81	2005	Honorary Director
Alice Dautry	75	2015	Honorary Director
Maelys Castella	59	2023	Independent Director
Jean van Rijckevorsel	-	1992	Honorary Director
Alan John Blinken	-	-	Honorary Director
Stef Heylen	-	2025	Representative Director
Dolca Thomas	55	2024	Independent Director
Fiona Powrie	-	2025	Independent Director
Thomas Fulton Wilson McKillop	82	2009	Honorary Director
Nefertiti Greene	54	2024	Independent Director

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com Nigeria's comment guidelines and agree to the terms described.

I Agree

UCBJY Comments

Write your thoughts about UCB SA ADR

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d72-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

NSE 30	5,249.90	+10.70	+0.20%
NSE All Share	143,520.52	+281.28	+0.20%
US 30	47,443.7	-272.7	-0.57%
US 500	6,795.5	-53.6	-0.78%
FTSE 100	9,720.51	+26.58	+0.27%
DAX	23,836.79	+68.83	+0.29%
South Africa Top 40	103,256.79	+373.96	+0.36%

Brent Oil	63.48	+1.10	+1.76%
Crude Oil WTI	59.64	+1.09	+1.86%
Gold	4,257.95	+3.05	+0.07%
Silver	56.560	+0.114	+0.20%
Copper	5.3050	+0.0050	+0.09%
London Cocoa	3,945.00	+164.00	+4.34%
London Wheat	163.70	-1.65	-1.00%

Nigeria 10Y	15.304	0.000	0.00%
Nigeria 2Y	15.726	+0.131	+0.84%
U.K. 10Y	4.4420	-0.0110	-0.25%
Germany 10Y	2.6913	+0.0138	+0.52%
U.S. 10Y	4.041	+0.021	+0.52%
U.S. 5Y	3.610	+0.012	+0.33%
U.S. 2Y	3.496	+0.005	+0.14%

Fidelitybk	19.100	-0.050	-0.26%
Zenith Bank	60.00	0.00	0.00%
UBA	36.45	+0.45	+1.25%
First HoldCo	31.05	-0.05	-0.16%
Guaranty Trust Holding	86.40	+0.30	+0.35%
Sterling Bank	7.150	0.000	0.00%
Dangote Cement	534.60	0.00	0.00%

Recent Quotes

Name	Price	Chg.	Chg. %
UCBJY	139.39	+1.52	+1.10%
603920	41.95	+1.18	+2.89%
Op-kehittyvät Osa.	120.600	-0.010	-0.01%

Market Movers

Name	Last	Chg. %	Vol.
Access Holdings	21.00	0.00%	103.29M
Ellah Lakes	13.85	+5.32%	82.71M
UBA	36.45	+1.25%	26.43M
Zenith Bank	60.00	0.00%	15.07M
Guaranty Trust Holding	86.40	+0.35%	10.42M
Lafarge Africa	134.00	+0.90%	6.40M
MTN Nigeria	470.60	+0.13%	2.86M

Name	Last	Chg. %	Vol.
Eternaoil	35.50	+19.49%	74.65K
Ikeja	30.250	+10.00%	4.22M
Nigerian Exchange	56.20	+9.98%	3.33M
Academy Press	7.35	+9.70%	1.02M
Omatek Ventures	1.17	+9.35%	2.52M
Cadbury Nig	57.90	+8.63%	826.12K
Secure Electronic Tech	0.80	+6.67%	7.52M

Name	Last	Chg. %	Vol.
Abbey Mortgage Bank	5.85	-10.00%	209.51K
Meyer	13.10	-9.97%	680.93K
Sunu Assurances	3.92	-9.89%	5.83M
Sovereign Trust Insurance Plc	2.70	-9.09%	7.48M
Linkassure	1.72	-8.02%	15.73M
Cileasing	4.96	-6.77%	538.97K
Eunisell Interlinked	81.000	-6.36%	1.70M